Mythbusting LCS in Pulmonology: Abnormal Exams (Part 3)

2021-11-18

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020. In part three of their five-part conversation, Dr. Debra Dyer, MD, and Dr. Gerard Silvestri, MD, discuss what a patient should expect if their lung cancer screening CT exam is abnormal. As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about m...

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.

In part three of their five-part conversation, Dr. Debra Dyer, MD, and Dr. Gerard Silvestri, MD, discuss what a patient should expect if their lung cancer screening CT exam is abnormal.

As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”

Dr. Gerard Silvestri is a lung cancer pulmonologist at the Medical University of South Carolina. He has served on the Data and Safety Monitoring Board of the national Prostate, Lung, Colorectal and Ovarian screening trial, representing the lung arm of the trial. Dr. Silvestri participates as a Steering Committee member and Task Group Chair on the American Cancer Society’s National Lung Cancer Screening Roundtable Steering Committee.

Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Comments (3)